These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17932969)

  • 1. Serologic and genetic markers do not aid in the determination of the clinical course and severity of patients with inflammatory bowel disease.
    Murphy SJ; Kornbluth A
    Inflamm Bowel Dis; 2008 Jan; 14(1):129-31; discussion 132-3. PubMed ID: 17932969
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD.
    Devlin SM; Dubinsky MC
    Inflamm Bowel Dis; 2008 Jan; 14(1):125-8; discussion 132-3. PubMed ID: 17932968
    [No Abstract]   [Full Text] [Related]  

  • 3. Can serologic markers help determine prognosis and guide therapy?
    Dubinsky M
    Dig Dis; 2010; 28(3):424-8. PubMed ID: 20926867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of serological and genetic markers in inflammatory bowel disease; strength and weakness of the studies.
    Peña AS
    Rev Esp Enferm Dig; 2003 Nov; 95(11):752-4, 749-51. PubMed ID: 14640872
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
    Mendoza JL; Abreu MT
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification.
    Dotan I
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):265-74. PubMed ID: 19072419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel diseases: where we are and where we should go.
    Tonutti E; Agostinis P; Bizzaro N
    Clin Chem Lab Med; 2014 Apr; 52(4):463-5. PubMed ID: 24583463
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the role of serological markers in the diagnosis of IBD?
    Dubinsky MC
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S185-6. PubMed ID: 18816787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers that differentiate early from late IBD.
    Huang C; Kugathasan S
    Dig Dis; 2012; 30(4):380-2. PubMed ID: 22796800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
    Hartman C; Eliakim R; Shamir R
    Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
    [No Abstract]   [Full Text] [Related]  

  • 11. Have genomic discoveries in inflammatory bowel disease translated into clinical progress?
    Weizman AV; Silverberg MS
    Curr Gastroenterol Rep; 2012 Apr; 14(2):139-45. PubMed ID: 22302508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
    Desreumaux P; Bourreille A; Colombel JF
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
    [No Abstract]   [Full Text] [Related]  

  • 13. [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases].
    Igaz I; Szőnyi M; Varga P; Topa L
    Orv Hetil; 2014 Mar; 155(13):487-91. PubMed ID: 24659741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical evaluation of serologic markers for inflammatory bowel disease.
    Austin GL; Herfarth HH; Sandler RS
    Clin Gastroenterol Hepatol; 2007 May; 5(5):545-7. PubMed ID: 17433787
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of autoantibodies in inflammatory bowel disease.
    Herszényi L; Tulassay Z
    Dig Dis; 2012; 30(2):201-7. PubMed ID: 22722439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
    Whiteoak SR; Felwick R; Sanchez-Elsner T; Fraser Cummings JR
    Inflamm Bowel Dis; 2015 May; 21(5):1160-5. PubMed ID: 25844960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia.
    Sabery N; Bass D
    Pediatrics; 2007 Jan; 119(1):e193-9. PubMed ID: 17158948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel diseases: from pathogenesis to laboratory testing.
    Basso D; Zambon CF; Plebani M
    Clin Chem Lab Med; 2014 Apr; 52(4):471-81. PubMed ID: 24108210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Yamamoto-Furusho JK; Fonseca-Camarillo G
    Inflamm Bowel Dis; 2015 Nov; 21(11):2683-95. PubMed ID: 26244649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic antiglycan antibodies in inflammatory bowel disease.
    Lakatos PL; Papp M; Rieder F
    Am J Gastroenterol; 2011 Mar; 106(3):406-12. PubMed ID: 21245832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.